Marco Hermesdorf
8PUBLICATIONS
68CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (8)
Sort by Publication Date:
|Nov 14, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.Aleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler
|Aug 04, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response.Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren
|Oct 16, 2024
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.Pascal Benkert, Aleksandra Maleska Maceski, Sabine Schaedelin
|Oct 30, 2023
The association of body mass index and body composition with plasma amyloid beta levels.Marco Hermesdorf, Hermann Esselmann, Barbara Morgado
|Jun 07, 2023
Serum neurofilament light and white matter characteristics in the general population: a longitudinal analysis.Marco Hermesdorf, Niklas Wulms, Aleksandra Maceski
Pageof 2
Frequent Collaborators
3 joint publications
Ahmed Abdelhak
3 joint publications
Alessandro Cagol
3 joint publications
David Leppert
3 joint publications
Jens Kuhle
3 joint publications
Riccardo Galbusera
3 joint publications
Johanna Oechtering
2 joint publications
Tilo Kircher
2 joint publications
Udo Dannlowski
2 joint publications
Stefanie Müller
2 joint publications
Igor Nenadić